Heap o' Links Wed Nov 10, 2021

Can’t make this one today pic.twitter.com/x0Y9GcMq3o

— Jack Posobiec (@JackPosobiec) November 9, 2021

The first oral antiviral for treating COVID-19, Merck & Co.’s molnupiravir, received approval from the U.K. Medicines and Healthcare products Regulatory Agency on 4 November. But the approval, for people at high risk of severe disease, comes as a prominent virologist has suggested using molnupiravir could do far more harm than good, potentially unleashing new, deadlier variants of SARS-CoV-2.… Molnupiravir, which Merck and Ridgeback Biotherapeutics developed from an earlier, experimental antiviral, works by interfering with viral replication, littering the viral genome with mutations until the virus can no longer reproduce.…

The way in which the CDC came to the conclusion that vaccines provided greater immunity than natural immunity is all but indecipherable, if not simply dishonest.

One more thing: the new COVID-19 antibody test is called SATiN and it uses Luciferase. No, I’m not kidding.